ATE292994T1 - Antimikrobielle zusammensetzungen welche vinylpyrrolidinon-cephalosporin-derivate und ein carbapenemantibiotikum oder ein beta- lactamaseinhibitor enthaten - Google Patents

Antimikrobielle zusammensetzungen welche vinylpyrrolidinon-cephalosporin-derivate und ein carbapenemantibiotikum oder ein beta- lactamaseinhibitor enthaten

Info

Publication number
ATE292994T1
ATE292994T1 AT98117009T AT98117009T ATE292994T1 AT E292994 T1 ATE292994 T1 AT E292994T1 AT 98117009 T AT98117009 T AT 98117009T AT 98117009 T AT98117009 T AT 98117009T AT E292994 T1 ATE292994 T1 AT E292994T1
Authority
AT
Austria
Prior art keywords
carbapenemantibiot
vinylpyrrolidinone
beta
compositions containing
antimicrobial compositions
Prior art date
Application number
AT98117009T
Other languages
English (en)
Inventor
Peter Angehrn
Ingrid Heinze-Krauss
Malcolm Page
G F Hans Richter
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of ATE292994T1 publication Critical patent/ATE292994T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT98117009T 1997-09-15 1998-09-09 Antimikrobielle zusammensetzungen welche vinylpyrrolidinon-cephalosporin-derivate und ein carbapenemantibiotikum oder ein beta- lactamaseinhibitor enthaten ATE292994T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97115997 1997-09-15

Publications (1)

Publication Number Publication Date
ATE292994T1 true ATE292994T1 (de) 2005-04-15

Family

ID=8227350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98117009T ATE292994T1 (de) 1997-09-15 1998-09-09 Antimikrobielle zusammensetzungen welche vinylpyrrolidinon-cephalosporin-derivate und ein carbapenemantibiotikum oder ein beta- lactamaseinhibitor enthaten

Country Status (16)

Country Link
US (1) US6150350A (de)
EP (1) EP0911030B1 (de)
JP (1) JP4621311B2 (de)
KR (1) KR100630012B1 (de)
CN (1) CN1186021C (de)
AR (1) AR013490A1 (de)
AT (1) ATE292994T1 (de)
AU (1) AU747285B2 (de)
BR (1) BR9803443A (de)
CA (1) CA2247232C (de)
DE (1) DE69829720T2 (de)
DK (1) DK0911030T3 (de)
ES (1) ES2241084T3 (de)
PT (1) PT911030E (de)
TR (1) TR199801835A2 (de)
ZA (1) ZA988399B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2335288A1 (en) * 1998-06-22 1999-12-29 F. Hoffmann-La Roche Ag Propenyl cephalosporin derivatives
WO2000032605A1 (en) * 1998-12-03 2000-06-08 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
JP4583559B2 (ja) * 2000-07-24 2010-11-17 栄研化学株式会社 Ｍｒｓａスクリーニング用培地
CN100384857C (zh) * 2003-11-28 2008-04-30 浙江永宁制药厂 耐β-内酰胺酶的头孢菌素酯化合物及其盐
CN112608369A (zh) * 2020-12-30 2021-04-06 中国海洋大学 一种具有抑菌活性的细菌素及其生产方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0347122A (ja) * 1989-02-21 1991-02-28 Banyu Pharmaceut Co Ltd 抗菌性組成物
EP0384410B1 (de) * 1989-02-21 1995-05-17 Banyu Pharmaceutical Co., Ltd. Zusammensetzung gegen Mikroben
GB9019743D0 (en) * 1990-09-10 1990-10-24 Beecham Group Plc Novel compounds
KR100214288B1 (ko) * 1993-04-16 1999-08-02 성재갑 안개서림 방지용 내마모성 피복조성물 및 이를 도포한 합성수지 성형품
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina
TW383308B (en) * 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
TR199700859T1 (xx) * 1995-02-27 1998-02-21 F. Hoffmann-La Roche Ag 3-Pirolidiliden-2-on-sefalosporin t�revleri.
ATE354577T1 (de) * 1996-11-06 2007-03-15 Basilea Pharmaceutica Ag Vinylpyrrolidinon-cephalosporin-derivate

Also Published As

Publication number Publication date
EP0911030A3 (de) 1999-10-13
AU8425198A (en) 1999-04-01
ES2241084T3 (es) 2005-10-16
EP0911030A2 (de) 1999-04-28
TR199801835A3 (tr) 1999-04-21
DK0911030T3 (da) 2005-08-01
ZA988399B (en) 1999-03-15
CA2247232A1 (en) 1999-03-15
CA2247232C (en) 2007-08-28
US6150350A (en) 2000-11-21
KR100630012B1 (ko) 2006-11-30
AR013490A1 (es) 2000-12-27
KR19990029769A (ko) 1999-04-26
JPH11140087A (ja) 1999-05-25
DE69829720T2 (de) 2006-03-09
BR9803443A (pt) 2000-02-08
EP0911030B1 (de) 2005-04-13
DE69829720D1 (de) 2005-05-19
AU747285B2 (en) 2002-05-16
CN1186021C (zh) 2005-01-26
CN1216246A (zh) 1999-05-12
TR199801835A2 (xx) 1999-04-21
PT911030E (pt) 2005-08-31
JP4621311B2 (ja) 2011-01-26

Similar Documents

Publication Publication Date Title
FI970317A7 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
FI962487L (fi) Rapamysiinijohdannaisia
DE69911065D1 (de) Alkoxyacrylamide photochrome beschichtungszusammensetzung und photochrome gegenstände
IL110455A0 (en) Pharmaceutical compositions for preventing the development of restenosis or intimal hyperplasia
NO20000125L (no) Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler
FI944310L (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
BR9400359A (pt) Implante de multicamadas
FI962483L (fi) Menetelmät ja materiaalit Staphylococcus aureusin detektoimiseksi
BR9712072A (pt) Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma
ATE233268T1 (de) Antibakterielle cephalosporinverbindungen
BR9307347A (pt) Derivados de 5-hidrazino-quinolina antimicrobianos
PL341813A1 (en) Fungicidal mixtures based on amidic compounds and derivatives of morpholine or piperidine
PL331470A1 (en) Azabicyclocarbamoyloxylic derivatives of mutiline for antibacterial applications
BR9500630A (pt) Composição absorvente sólida e artigo fabricado incluindo uma composição absorvente sólida
BR9407592A (pt) Aplicador de lubrificante em pó
DE69636506D1 (de) Antibakterielle und fungizide Kette
DE69829720D1 (de) Antimikrobielle Zusammensetzungen welche Vinylpyrrolidinon-Cephalosporin-Derivate und ein Carbapenemantibiotikum oder ein beta-lactamaseinhibitor enthaten
DE69929621D1 (de) Vielteilige antimikrobielle sterilisationsmittel und verfahren
PL341340A1 (en) Fungicidal mixtures on the basis of amidic compounds and derivatives of morpholine or piperidine
DE69809793D1 (de) Synergistische fungizide und/oder bakterizide zusammensetzungen
DE69605988D1 (de) Synergistische antimikrobielle Zusammensetzung
FR2753743B1 (fr) Nouveau type de store ou article similaire
FI970318L (fi) Antiproliferatiivisina aineina ja Garft-inhibiitoreina käyttökelpoisia yhdisteitä
HUP9602872A3 (en) Penem derivatives and antimicrobial agent containing the same
DE69816057D1 (de) Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0911030

Country of ref document: EP